Aspirin in Reducing Events in the Elderly
Public ClinicalTrials.gov record NCT01038583. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
ASPREE-XT is a post-treatment, longitudinal observational follow-up study of ASPREE participants \[ASPREE Investigator Group, 2013; www.aspree.org; McNeil et al 2017\]. Although the ASPREE trial medication was ceased, the study activity was not stopped and ASPREE participants are continuing with scheduled visits and phone calls. An observational follow-up phase (ASPREE-XT), began in January, 2018. This will enable the monitoring of possible delayed effects of aspirin treatment, primarily on cancer incidence, metastases and mortality. In addition to monitoring the incidence of malignancy within the ASPREE cohort, the opportunity will be taken to observe any other residual effects of aspirin on the endpoints being monitored in the cohort. Continuity of contact with study participants is the key to retention of the cohort for any ongoing or future studies.
Study identification
- NCT ID
- NCT01038583
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 19,114 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2010 (Actual)
- Primary completion
- Dec 2017 (Actual)
- Completion
- Apr 2024 (Estimated)
- Last update posted
- Apr 5, 2021
2010 – 2024
United States locations
- U.S. sites
- 33
- U.S. states
- 18
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Palo Alto Medical Foundation Research Institute | Palo Alto | California | 94301 | — |
| Howard University | Washington D.C. | District of Columbia | 20060 | — |
| University of Florida Department of Aging and Geriatrics | Gainesville | Florida | 32611 | — |
| Morehouse School of Medicine | Atlanta | Georgia | 30310 | — |
| Emory/ Atlanta VAMC | Atlanta | Georgia | 30322 | — |
| Georgia Health Sciences University | Augusta | Georgia | 30912 | — |
| Rush Alzheimer's Disease Center | Chicago | Illinois | 60612 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Kansas University Medical Center | Kansas City | Kansas | 66106 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
| Mary Bird Perkins Our Lady of the Lake Cancer Center | Baton Rouge | Louisiana | 70809 | — |
| LSU Health Sciences- New Orleans | New Orleans | Louisiana | 70112 | — |
| Tulane Medical Center | New Orleans | Louisiana | 70112 | — |
| LSU Health Sciences- Shreveport | Shreveport | Louisiana | 71130 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Detroit Clinical Research Center | Novi | Michigan | 48377 | — |
| HealthPartners Research Institute | Minneapolis | Minnesota | 55425 | — |
| Phalen Village Clinic | Saint Paul | Minnesota | 55106 | — |
| Central Jersey Medical Center | Elizabeth | New Jersey | 07202 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| Wake Forest University Baptist Medical Center | Greensboro | North Carolina | 27408 | — |
| The Brody School of Medicine at ECU | Greenville | North Carolina | 27834 | — |
| Albert Einstein Medical Center | Philadelphia | Pennsylvania | 19141 | — |
| University of Pittsburgh Health Sciences Research Center | Pittsburgh | Pennsylvania | 15260 | — |
| Memorial Hospital of Rhode Island | Pawtucket | Rhode Island | 02860 | — |
| University of Tennessee Health Science Center | Memphis | Tennessee | 38105 | — |
| University of Texas Southwestern Medical Center at Dallas | Dallas | Texas | 75390 | — |
| University of TX Medical Branch | Galveston | Texas | 77555 | — |
| Regional Academic Health Center | Harlingen | Texas | 78550 | — |
| UT Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01038583, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01038583 live on ClinicalTrials.gov.